Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Exploring the metabolic and molecular benefits of methyl donor supplementation in a model of metabolic and fatty liver disease
Angel Vazquez-Esqueda; Rebeca Rosas-Campos; Rebeca Escutia-Gutiérrez; Ricardo de la Rosa-Bibiano; Samael Rodríguez-Sanabria; Marina Galicia-Moreno; Juan Armendáriz-Borunda; Ana Sandoval-Rodríguez;
Ann Hepatol. 2024;29 Supl 2:
P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY
Ricardo De la Rosa-Bibiano; Rebeca Escutia-Gutiérrez; Eira Cerda-Reyes; Juan Manuel Aguilar; Ana Soledad Sandoval-Rodríguez; Juan Armendáriz-Borunda;
Ann Hepatol. 2023;28 Supl 1:
O-24 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS
Hipólito Otoniel Miranda-Roblero; Hugo Christian Monroy-Ramírez; Marina Galicia-Moreno; Ana Sandoval-Rodriguez; Arturo Santos; Juan Armendáriz-Borunda;
Ann Hepatol. 2023;28 Supl 1: